Tetrameric PKM2 has shown a protective role against the progression of DKD and chronic kidney disease (CKD) in type 1 and type 2 diabetes from clinical individuals, partly by rewiring the plethora of carbon compounds to catabolism, reducing toxic glucose metabolites, and thereby circumventing energy consumption and redox stress from synthesis (3, 6). This evidence concerns the gene PKM and chronic kidney disease.